National Health Investors (NHI) Current Deferred Revenue (2009 - 2026)

National Health Investors (NHI) has 18 years of Current Deferred Revenue data on file, last reported at $5.2 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 26.94% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 26.94% YoY) and the FY2025 annual result came in at $5.0 million, up 16.81% from the prior year.
• Current Deferred Revenue rose to $5.2 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $6.0 million in Q4 2023 to a low of $4.0 million in Q3 2025.
• A 5-year average of $4.8 million and a median of $5.0 million in 2025 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue plunged 60.95% — and 2026, when it grew 26.94%.
• Tracing NHI's Current Deferred Revenue over 5 years: stood at $5.1 million in 2022, then rose by 18.94% to $6.0 million in 2023, then fell by 28.82% to $4.3 million in 2024, then grew by 16.81% to $5.0 million in 2025, then increased by 4.22% to $5.2 million in 2026.
• The last three Current Deferred Revenue figures came in at $5.2 million (Q1 2026), $5.0 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.